Cargando…

Correction of acknowledgments: PD-L1 testing in non-small cell lung cancer: past, present, and future

Detalles Bibliográficos
Autores principales:	Kim, Hyojin, Chung, Jin-Haeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093281/ https://www.ncbi.nlm.nih.gov/pubmed/32160690 http://dx.doi.org/10.4132/jptm.2020.02.17

Ejemplares similares

PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
por: Kim, Hyojin, et al.
Publicado: (2019)

Corrigendum to “Herpesvirus BACs: Past, Present, and Future”
por: Warden, Charles, et al.
Publicado: (2019)

Corrigendum to “The Past, Present, and Future of Public Health Surveillance”
por: Choi, Bernard C. K.
Publicado: (2018)

Corrigendum: Correction of Acknowledgments: Epidemiology of Childhood Obesity in Korea
por: Ha, Kyoung Hwa, et al.
Publicado: (2017)

Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
por: D'Angelo, S. P., et al.
Publicado: (2015)

Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
por: Kumar, Vijay
Publicado: (2018)

CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer
por: Shin, Eung Jin, et al.
Publicado: (2018)

Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
Publicado: (2022)

Health accounts from past to present for a political arithmetic
Publicado: (2021)

PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
por: Kim, Hyojin, et al.
Publicado: (2017)

Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
por: Jain, Samagra, et al.
Publicado: (2022)

Corrigendum: Correction of the Acknowledgment.Prevalence and management status of urologic disease in geriatric hospitals in South Korea: A population-based analysis
por: Suh, Jungyo, et al.
Publicado: (2018)

Corrigendum: Correction of Acknowledgments. Association between Serum Fibroblast Growth Factor 21 Levels and Bone Mineral Density in Postmenopausal Women
por: Choi, Hoon Sung, et al.
Publicado: (2018)

Immunotherapy in non‐small cell lung cancer: The past, the present, and the future
por: Lu, Meng, et al.
Publicado: (2019)

PD-L1 Biomolecules Associated with Clinical Features in Non-Melanoma Skin Cancer [Corrigendum]
Publicado: (2023)

CORRIGENDUM: Correction of acknowledgements & funding/grant support: The effect of curative resection on fecal microbiota in patients with colorectal cancer: a prospective pilot study
por: Park, Sung Sil, et al.
Publicado: (2021)

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078]
por: Banna, G.L., et al.
Publicado: (2021)

Immunotherapy in non-small cell lung cancer: Past, present, and future directions
por: Punekar, Salman R., et al.
Publicado: (2022)

Corrigendum: Acknowledgments. Effect of Photoselective Vaporization Prostatectomy on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia With or Without Intravesical Prostatic Protrusion
por: Kim, Myung Soo, et al.
Publicado: (2013)

Correction: Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

Correction Notice for “Real-World Data on Liquid Biopsy Use in Non-Small Cell Lung Cancer in the Community Setting” by Dvir et al
Publicado: (2021)

Corrigendum to “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer”
por: Bari, Shahla, et al.
Publicado: (2019)

Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
por: Uras, Iris Z., et al.
Publicado: (2020)

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
por: Chevallier, Mathieu, et al.
Publicado: (2021)

Biomarker testing of cytology specimens in personalized medicine for lung cancer patients
por: Kim, Hyojin, et al.
Publicado: (2022)

Novel Genetic Associations Between Lung Cancer and Indoor Radon Exposure
por: Choi, Jung Ran, et al.
Publicado: (2018)

Novel Genetic Associations Between Lung Cancer and Indoor Radon Exposure
por: Choi, Jung Ran, et al.
Publicado: (2018)

Change of acknowledgments in “The relationship between dental graduate students’ MBTI types and academic achievement in problem-based learning„
Publicado: (2015)

Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum]
Publicado: (2021)

Correction of Ethics Statement: Metastatic Insulinoma Presenting as a Liver Cyst
por: Li, Hua, et al.
Publicado: (2019)

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
Publicado: (2021)

Lung Interstitial Macrophages: Past, Present, and Future
por: Schyns, Joey, et al.
Publicado: (2018)

miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum]
Publicado: (2020)

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
por: Redman, Jason M., et al.
Publicado: (2023)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Small Vessel Cerebrovascular Disease: The Past, Present, and Future
por: Behrouz, Réza, et al.
Publicado: (2012)

The Past, Present, and Future in Management of Small Renal Masses
por: Ha, Sarah C., et al.
Publicado: (2015)

Correction: T cell clonality assessment: past, present and future
Publicado: (2018)

Correction: Selective laser trabeculoplasty: past, present, and future
por: Garg, A., et al.
Publicado: (2019)

Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future
por: Wakuda, Kazushige
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c8nq6bc54ev0e03omojam744pr